UnitedHealth Group Options Trading: A Deep Dive into Market Sentiment
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and … » Read more about: UnitedHealth Group Options Trading: A Deep Dive into Market Sentiment »
Read MoreETFs have transformed European markets — but choose one carefully
It was 25 years ago that the world of investment and funds in Europe experienced a revolution, with the arrival of the continent’s first exchange- traded funds (ETFs). The choice available now is staggering and, as with all transformative changes, there is a mix of hype, extremely useful stuff, and frankly, scary elements. I wrote my first book about ETFs for the FT back in 2009.
» Read more about: ETFs have transformed European markets — but choose one carefully »
Read MoreSteve Hanke tells BI investors are shrugging off serious risks — and Trump is causing historic uncertainty
Investors are brushing off the Iran-Israel conflict as another brief distraction on the road to fresh highs. Steve Hanke thinks their complacency could prove costly.
The professor of applied economics at Johns Hopkins University told Business Insider that Israel has been directly or indirectly tied to seven of the 19 major geopolitical events since 1950.
Read MoreThe Burst
2 Hot Stocks That Could 4x
Tech stocks are out of favor at the moment. You don’t need to look much further than Peloton, down over 80% from its highs to know that high growth stocks have been tossed out of portfolios with abandon.
And while some companies deserve to have their valuations chopped up, others have strong fundamentals and are growing at a rapid pace yet their share prices are not reflecting the positive news.
» Read more about: 2 Hot Stocks That Could 4x »
Read MoreThe Ivy
Alert: Get Pharma Royalties Plus 58.1% Upside
Investment Alert: Buy Royalty Pharma (RPRX) Under $33/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
How would you like a cut of those lucrative pharmaceutical royalties that famously mint money?
» Read more about: Alert: Get Pharma Royalties Plus 58.1% Upside »
Read More